How to Buy Arrivent Biopharma Stock
Arrivent Biopharma Inc
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers.
Arrivent Biopharma stock last closed at $21.63, down 1.82% from the previous day, and has increased 17.49% in one year. It has overperformed other stocks in the Biotechnology industry by 0.88 percentage points. Arrivent Biopharma stock is currently +39.82% from its 52-week low of $15.47, and -40.53% from its 52-week high of $36.37.
There are currently 34.21M AVBP shares outstanding. The market value of AVBP is $740.02M. In the last 24 hours, 175,000 AVBP shares were traded.
How to Buy Arrivent Biopharma Stock
Not sure how to invest in Arrivent Biopharma stock? Here's how.
- Choose where to buy Arrivent Biopharma stock: You need to decide on a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Arrivent Biopharma stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Select your method of payment and add your info.
- Evaluate Arrivent Biopharma stock: The Arrivent Biopharma ticker symbol is AVBP. Is Arrivent Biopharma stock a good investment? Should you buy shares of AVBP? How do AVBP's underlying business fundamentals look? Do top analysts think Arrivent Biopharma is a good buy? Why has AVBP's stock price moved recently? (Hint: Our stock research tools can help you understand if AVBP is a good stock to buy).
- Place your AVBP buy order: Decide if you will purchase AVBP shares at the current market price or use a limit order to purchase AVBP shares at a specific price.
- Keep tabs on your AVBP investment: Create a watchlist to monitor your investment in Arrivent Biopharma stock.
Step 1: Choose where to buy Arrivent Biopharma stock
You need an online brokerage account to access the NASDAQ market and buy AVBP shares.
Our favorite brokerage: eToro
Based on our experience, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Tech to Healthcare, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can buy AVBP today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to start your new trading account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you've opened your account on a good stock buying app, you can securely and quickly fund your account:
Watch the tutorial below for more details transferring money into your investment account.
Step 4: Evaluate Arrivent Biopharma stock
After you have decided on the best place to buy Arrivent Biopharma stock, it's critical to evaluate their stock before you buy, so you truly understand the risk as well as the opportunity.
Arrivent Biopharma shares data
AVBP Due Diligence Checks
WallStreetZen was built to help everyday investors do more accurate fundamental analysis in less time.
You can view all of the due diligence checks on AVBP's stock page.
Is AVBP stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge AVBP's intrinsic value.
Using relative valuations measures:
- AVBP could be undervalued based on its P/B ratio of 3.65x, relative to Biotechnology industry P/B ratio of 4.62x
You can do additional valuation analysis on AVBP's stock here.
AVBP Financial Health Summary
Positive Financial Indicators:
- AVBP has a low debt to equity ratio of 0.06.
- AVBP has cash burn of 119592000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the AVBP balance sheet.
- There are more short-term assets than long-term liabilities on the AVBP balance sheet.
- AVBP has $176.08M in cash and short term investments. This is sufficient to cover its annual cash burn of $119.59M.
Do Wall Street analysts think it's a good time to buy Arrivent Biopharma stock
Out of 7 Equities analysts who give forecasts on AVBP, the consensus analyst rating on Arrivent Biopharma is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
Latest AVBP Analyst Upgrades/Downgrades
Robert Burns, a bottom 1% analyst from HC Wainwright & Co. maintains AVBP with a buy rating and raises their AVBP price target from $39.00 to $40.00, on May 14, 2025.
Kalpit Patel, a bottom 10% analyst from B. Riley Securities initiates coverage on AVBP with a strong buy rating and announces their AVBP price target of $37.00, on Mar 20, 2025.
You can dig deeper into what analysts are forecasting on the Arrivent Biopharma stock forecast page.
AVBP Trading Indicators
Who is buying/selling AVBP?
Over the last year, executives and large shareholders at AVBP have bought more shares than they have sold.
Robin Lachapelle, Chief Operating Officer of AVBP, was the latest AVBP insider to buy. They bought $45,128.60 worth of AVBP shares on Sep 19, 2024.
Research more about who owns AVBP shares here.
Does AVBP stock generate passive income?
No, Arrivent Biopharma doesn't provide an income stream by paying out dividends.
What others are saying about AVBP
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your AVBP buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually fine. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific price, place a limit order.
Hit the Open Trade button and your broker will place the order.
If you require more help with buying stocks on eToro, click the how to video below:
Step 6: Keep tabs on your AVBP investment
Now that you own some AVBP shares, you'll want to keep up with your investment.
Add AVBP to a watchlist to track the latest developments regarding your AVBP stock.
AVBP Feed
How to Buy Stock in Arrivent Biopharma
To reiterate, here are the 6 steps to buy Arrivent Biopharma stock:
- Choose where to buy Arrivent Biopharma stock
- Sign up for your brokerage account
- Fund your brokerage account
- Evaluate Arrivent Biopharma stock
- Place your AVBP buy order
- Keep tabs on your AVBP investment
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Arrivent Biopharma, hit the button below to create your watchlist.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.